ExodusPoint Capital Management, LP

Q3 2021 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2021
Date filed
11/15/2021
Form type
13F-HR
Num holdings
2,031
Total value ($000)
$7,410,131
Net value change ($000)
-1,631,804 (-18.0%)
New positions
660
Sold out positions
873
Turnover %
46.6%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AMD 61,019 NEW
CSGP 57,918 562.2%
ED 50,904 743.3%
EXC 42,435 NEW
DE 41,354 NEW
EEFT 39,830 2079.9%
NVDA 36,022 NEW
DOCU 33,694 NEW
FANG 33,472 295.9%
EEM 32,527 510.5%
Top Reduces (Value $000, Stocks/ETFs)
MSFT -448,487 -93.2%
AMZN -365,837 -100.0%
MRNA -77,715 -98.3%
PYPL -43,440 -94.8%
ETR -41,940 -55.8%
LIN -41,535 -94.7%
SO -38,242 -80.8%
CNP -36,054 -100.0%
PRA Health Sciences, Inc. -32,241 -100.0%
CRM -27,735 -81.8%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 734,203 (9.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 PYTHAGOREAN TRADING, LLC